 |
Articles: Hematology/Oncology |
Prior Articles
Platelet-Derived Transforming Growth Factor-beta Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
Cancer Research, 10/06/09
Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70–Mediated Inflammatory Killing of Normal Pancreas
Cancer Research, 10/06/09 Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity via Membrane-Bound Transforming Growth Factor-beta1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses
Cancer Research, 10/06/09 Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells
Clinical and Experimental Immunology, 10/05/09 Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia
Clinical and Experimental Immunology, 10/05/09 Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Clinical Cancer Research, 10/01/09 CD4+CD45RA+CXCR4+ lymphocytes are inversely associated with progression in stages I–III melanoma patients
Cancer Immunology, Immunotherapy, 09/30/09 Pulmonary periarterial inflammation in fatal asthma
Clinical and Experimental Allergy, 09/29/09 Surface-exposed Histone-like protein A modulates adherence of Streptococcus gallolyticus to colon adenocarcinoma cells
Infection and Immunity, 09/29/09 A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses
International Journal of Cancer, 09/29/09 Update of the guidelines for lupus anticoagulant detection
Journal of Thrombosis and Haemostasis, 09/28/09 IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 09/28/09 Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
Cancer Science, 09/28/09 Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation
Journal of Immunology, 09/28/09 Phosphorothioate-Modified TLR9 Ligands Protect Cancer Cells against TRAIL-Induced Apoptosis
Journal of Immunology, 09/28/09 Immunomodulation of Multiple Myeloma Bone Disease
Clinical Reviews in Bone and Mineral Metabolism, 09/25/09 Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy
The Oncologist, 09/25/09 Biochemical analysis of CTLA-4 immunoreactive material from human blood
BMC Immunology, 09/24/09
Free full text
Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations
Cancer Immunology, Immunotherapy, 09/23/09
Exclusive Author Commentary Prognostic value of CD208-positive cell infiltration in gastric cancer
Cancer Immunology, Immunotherapy, 09/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Allergy, Clinical Immunology, Annals of Allergy, Asthma, and Immunology
more...
|
250 Available Pages
|
|
